240 related articles for article (PubMed ID: 21068144)
1. Polysaccharide krestin is a novel TLR2 agonist that mediates inhibition of tumor growth via stimulation of CD8 T cells and NK cells.
Lu H; Yang Y; Gad E; Wenner CA; Chang A; Larson ER; Dang Y; Martzen M; Standish LJ; Disis ML
Clin Cancer Res; 2011 Jan; 17(1):67-76. PubMed ID: 21068144
[TBL] [Abstract][Full Text] [Related]
2. TLR2 agonist PSK activates human NK cells and enhances the antitumor effect of HER2-targeted monoclonal antibody therapy.
Lu H; Yang Y; Gad E; Inatsuka C; Wenner CA; Disis ML; Standish LJ
Clin Cancer Res; 2011 Nov; 17(21):6742-53. PubMed ID: 21918170
[TBL] [Abstract][Full Text] [Related]
3. Protein-bound polysaccharide activates dendritic cells and enhances OVA-specific T cell response as vaccine adjuvant.
Engel AL; Sun GC; Gad E; Rastetter LR; Strobe K; Yang Y; Dang Y; Disis ML; Lu H
Immunobiology; 2013 Dec; 218(12):1468-76. PubMed ID: 23735481
[TBL] [Abstract][Full Text] [Related]
4. The TLR2 agonist in polysaccharide-K is a structurally distinct lipid which acts synergistically with the protein-bound β-glucan.
Quayle K; Coy C; Standish L; Lu H
J Nat Med; 2015 Apr; 69(2):198-208. PubMed ID: 25510899
[TBL] [Abstract][Full Text] [Related]
5. Polysaccharide-K (PSK) increases p21(WAF/Cip1) and promotes apoptosis in pancreatic cancer cells.
Rosendahl AH; Sun C; Wu D; Andersson R
Pancreatology; 2012; 12(6):467-74. PubMed ID: 23217280
[TBL] [Abstract][Full Text] [Related]
6. Suppression of hepatic natural killer activity by liver metastasis of cancer and restoration of killer activity by oral administration of a Basidomycetes-derived polysaccharide, PSK.
Suo J; Tanaka N; Hizuta A; Yunoki S; Orita K
Acta Med Okayama; 1994 Oct; 48(5):237-42. PubMed ID: 7863794
[TBL] [Abstract][Full Text] [Related]
7. Krestin (PSK).
Tsukagoshi S; Hashimoto Y; Fujii G; Kobayashi H; Nomoto K; Orita K
Cancer Treat Rev; 1984 Jun; 11(2):131-55. PubMed ID: 6238674
[TBL] [Abstract][Full Text] [Related]
8. Oral administration of PSK can improve the impaired anti-tumor CD4+ T-cell response in gut-associated lymphoid tissue (GALT) of specific-pathogen-free mice.
Harada M; Matsunaga K; Oguchi Y; Iijima H; Tamada K; Abe K; Takenoyama M; Ito O; Kimura G; Nomoto K
Int J Cancer; 1997 Jan; 70(3):362-72. PubMed ID: 9033641
[TBL] [Abstract][Full Text] [Related]
9. Gamma delta T cells are activated by polysaccharide K (PSK) and contribute to the anti-tumor effect of PSK.
Inatsuka C; Yang Y; Gad E; Rastetter L; Disis ML; Lu H
Cancer Immunol Immunother; 2013 Aug; 62(8):1335-45. PubMed ID: 23685781
[TBL] [Abstract][Full Text] [Related]
10. Combined TLR2/4-activated dendritic/tumor cell fusions induce augmented cytotoxic T lymphocytes.
Koido S; Homma S; Okamoto M; Namiki Y; Takakura K; Takahara A; Odahara S; Tsukinaga S; Yukawa T; Mitobe J; Matsudaira H; Nagatsuma K; Uchiyama K; Kajihara M; Arihiro S; Imazu H; Arakawa H; Kan S; Komita H; Ito M; Ohkusa T; Gong J; Tajiri H
PLoS One; 2013; 8(3):e59280. PubMed ID: 23555011
[TBL] [Abstract][Full Text] [Related]
11. Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2.
Kariya Y; Inoue N; Kihara T; Okamoto N; Sugie K; Mori T; Uchida A
Immunol Lett; 1992 Feb; 31(3):241-5. PubMed ID: 1372283
[TBL] [Abstract][Full Text] [Related]
12. Dendritic cells, macrophages, NK and CD8
Lucinda N; Figueiredo MM; Pessoa NL; Santos BS; Lima GK; Freitas AM; Machado AM; Kroon EG; Antonelli LR; Campos MA
Virol J; 2017 Feb; 14(1):37. PubMed ID: 28222752
[TBL] [Abstract][Full Text] [Related]
13. PSK as a chemopreventive agent.
Kobayashi H; Matsunaga K; Fujii M
Cancer Epidemiol Biomarkers Prev; 1993; 2(3):271-6. PubMed ID: 8318880
[TBL] [Abstract][Full Text] [Related]
14. [Antitumor effect of intratumoral administration of a Coriolus preparation, PSK: inhibition of tumor invasion in vitro].
Ebina T; Murata K
Gan To Kagaku Ryoho; 1994 Sep; 21(13):2241-3. PubMed ID: 7944450
[TBL] [Abstract][Full Text] [Related]
15. A Toll-like receptor 2 agonist-fused antigen enhanced antitumor immunity by increasing antigen presentation and the CD8 memory T cells population.
Wu CC; Liu SJ; Chen HW; Shen KY; Leng CH
Oncotarget; 2016 May; 7(21):30804-19. PubMed ID: 27127171
[TBL] [Abstract][Full Text] [Related]
16. Polysaccharide Agaricus blazei Murill stimulates myeloid derived suppressor cell differentiation from M2 to M1 type, which mediates inhibition of tumour immune-evasion via the Toll-like receptor 2 pathway.
Liu Y; Zhang L; Zhu X; Wang Y; Liu W; Gong W
Immunology; 2015 Nov; 146(3):379-91. PubMed ID: 26194418
[TBL] [Abstract][Full Text] [Related]
17. Protein bound polysaccharide PSK abrogates more efficiently experimental metastases derived from H-2 negative than from H-2 positive fibrosarcoma tumor clones.
Algarra I; Collado A; Garrido F
J Exp Clin Cancer Res; 1997 Dec; 16(4):373-80. PubMed ID: 9505208
[TBL] [Abstract][Full Text] [Related]
18. Antitumor effect of PSK at a distant site: inductions of interleukin-8-like factor and macrophage chemotactic factor in murine tumor.
Ebina T; Murata K
Jpn J Cancer Res; 1990 Dec; 81(12):1307-13. PubMed ID: 2126000
[TBL] [Abstract][Full Text] [Related]
19. TLR2 engagement on dendritic cells promotes high frequency effector and memory CD4 T cell responses.
Chandran SS; Verhoeven D; Teijaro JR; Fenton MJ; Farber DL
J Immunol; 2009 Dec; 183(12):7832-41. PubMed ID: 19933854
[TBL] [Abstract][Full Text] [Related]
20. Efficient induction of antitumor immunity by synthetic toll-like receptor ligand-peptide conjugates.
Zom GG; Khan S; Britten CM; Sommandas V; Camps MG; Loof NM; Budden CF; Meeuwenoord NJ; Filippov DV; van der Marel GA; Overkleeft HS; Melief CJ; Ossendorp F
Cancer Immunol Res; 2014 Aug; 2(8):756-64. PubMed ID: 24950688
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
